They are primarily considered for research and are often used "off-label" in clinical settings
doi:10.1016/0196-9781(86)90148-8 Kato N, Honda Y, Ebihara S, Naruse H, Takahashi Y
La condotta corretta non sospendere il GLP-1, ma valutare una riduzione della dose di insulina o della sulfonilurea, con monitoraggio glicemico appropriato
The same rebound effect has been seen with other chronic conditions (e.g., diabetes, etc.) that the GLP1 receptor agonist may have been managing
Vitamin C drips like C-Boost are useful for immune support and can positively contribute to care for a large variety of conditions including EBV, Lyme, urinary tract infections, chronic viral and respiratory conditions.